Brazil Says It’s Ready and Willing to Break AIDS Drugs Patents

According to Pedro Chequer, the coordinator of Brazil’s Sexually Transmitted Disease/Aids program, the country may break patents with pharmaceutical companies and manufacture generic versions of up to a total of five brand name retroviral drugs.

“There is a concrete possibility that we will break patents under existing international agreements. And we now have the technical capacity to begin manufacturing next year. We will be able to deal with the manufacturing process all the way from the molecular level to the finished product,” he said.


However, Chequer refused to specifiy which AIDS drugs, out of the eight Brazil presently has to import, could have their patents broken.


He also did not disclose the amount of money Brazil was spending on research, but he did say that the Brazilian Development Bank (BNDES), along with laboratories in both the public and private sectors, were running studies on the country’s capabilities with the objective of eventually creating a new reality with new perspectives in the pharmaceutical area.


“What this means is that besides the seven AIDS drugs we already make generic versions of, we will expand our production capacity significantly with another three to five generic versions of other brand name drugs,” said Chequer.


The justification for breaking patents, explained Chequer, is that Brazil is forced to spend too much on imported AIDS drugs which could be made domestically in public or private labs.


He points out that around 80% of his budget (some US$ 165 million or R$ 450 million) goes to paying for the importation of only seven drugs that are used in treating AIDS.


Brazil’s Sexually Transmitted Disease/AIDS program, as part of the Brazilian public health network (SUS), supplies approximately 150,000 HIV-positive patients with 15 drugs free of charge to treat the disease and keep it under control.


Out of those 15 drugs, seven are now produced in Brazil in generic versions and the remaining eight are imported. Among the eight imported drugs is the newest in the so-called AIDS cocktail, Aazanavir, which is made in the United States by Bristol-Myers Squibb.


Agência Brasil
Translator: Allen Bennett

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Paulo Coelho Wants “War Criminal” Tony Blair Out of 2016 Rio Olympics

Brazilian best-selling author and Brazil’s best-known writer, Paulo Coelho, is making it clear he ...

Opposition? What Opposition?

Political leaders in Brazil have been playing to the gallery and a high price ...

RAPIDINHAS

When he was first elected in 1994, president Cardoso promised a sweeping political reform, ...

Brazil’s Unemployment Down for December and the Year 2008

In Brazil, the unemployment rate in the country's six largest metropolitan regions was 7.9% ...

Brazil Bishop Calls River Transposition Project Antiethic

During a hearing held last week at the Brazilian Senate on the São Francisco ...

Back on Earth Brazil’s First Astronaut Pays Tribute to Dumont

Lt Col Marcos Pontes, the first Brazilian to go into space, has returned to ...

Brazil on Course to Reach US$ 33 Billion Surplus

Brazil is very close to reaching the trade balance surplus forecasted for 2004. The ...

Brazil Injects Close to US$ 3 Billion in Economy to Halt Rising Dollar

The Brazilian Central Bank announced on Thursday, October 16, further measures to ensure liquidity ...

A Call to Peace

Look into the eyes of most Brazilians while speaking of Iraq, and you will ...